CHU Gabriel Montpied — Clermont-Ferrand

Public research footprint of CHU Gabriel Montpied, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Bleeding · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Carcinoma, Non-Small-Cell Lung · Chronic Kidney Disease (CKD)

Recently updated registry entries

NCT06707688 — Abbott Medical - VERITAS Study (Active Not Recruiting)
NCT06077760 — A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… (Recruiting)
NCT06875310 — A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Gabriel Montpied?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.